clinical observations of 26 patients with tongue , oral cavity and oropharyngeal cancer receiving telegammatherapy by dynamic dose fractionation scheme in combination with metronidazole ( mz ) and of 38 patients from control group treated by identical schedule without mz suggest that mz favors increasing of the radiation damage in tumors of those sites without changing the character or intensifying early radiation reactions .
C0040408
tongue
C0226896
oral cavity